Australian tech success needs skilled migration – and not the ‘gig economy’ type
ACS report highlights skilled ICT migrants have high employment rates in Australia, with over 90% finding jobs and 80% within the IT sector Skilled [more…]
Top 10 at 11: Which biotech receives ethics approval for a Phase 3 trial?
Stockhead’s Top 10 at 11, published each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, [more…]
Market Highlights: Gold flies to record high after Powell speech, and 5 ASX small caps to watch today
Wall Street rebounds after Jerome Powell speech Gold is at record high Why AI investing is more than just Nvidia The ASX is [more…]
Long Shortz with Belararox: Active at PDAC and in Argentina
Stockhead’s Ashtyn Hiron sits down with Belararox (ASX:BRX) Arturo Guardiola to get the short end of the long story on the company’s latest news. Belararox [more…]
Let’s get technical: Marion finds her calling out in the bush
In the lead-up to International Women’s Day on 8 March, we’re celebrating some of the champion women of the resources industry Marion Bush is technical [more…]
Which ASX uranium stocks are in the development pipeline?
A shortage of material and tight spot market has seen uranium prices rise fivefold to US$93.5/lb in the past six years It has brought a [more…]
End in sight as Opthea looks to be key player in US$10 billion wet AMD market
Opthea look to transform standard of care treatment for wet AMD to improve vision outcomes Two Phase 3 trials are underway investigating lead drug OPT-302 [more…]
Weed Week: Cannabis can ‘kill melanoma’; and Germany legalises weed possession
Study shows cannabis can kill melanoma cells Germany has voted to legalise cannabis possession The best performing ASX weed stocks over the past month [more…]
ASX Health Winners February: Law of attrition applies but biotech is a long term game; Nyrada up 5x last month
ASX Health Index down -1.5% for February 76 biotechs rose, and 78 fell during the month But essentially, biotech is a long term game for [more…]
Viridis nabs the final puzzle piece in its plan to consolidate a corridor of REE landholdings in Brazil
Viridis has signed an agreement to secure additional ground at the Colossus rare earths project This expansion provides the company with a dominant land footprint [more…]
